Dr. Jennifer R. Rider has over 20 years of experience in cancer epidemiology and real-world evidence research. Her academic career spanned faculty roles at the Harvard Medical School, Harvard T.H. Chan School of Public Health Harvard, and Boston University School of Public Health. She first joined ConcertAI in 2020, moving from there to lead Aetion’s Oncology Center of Excellence. This new role marks her return to ConcertAI in a position of broader responsibility overseeing all regulatory applications of the company’s definitive RWE based on the authoritative Patient360™ specification.
Jennifer earned her ScD in epidemiology from Harvard T.H. Chan School of Public Health, her Master of Public Health from the University of Massachusetts Amherst, and her BS from the University of Wisconsin-Madison. With over 100 publications, posters, and abstracts, her research has been published in top-tier journals including Clinical Cancer Research and European Urology.